CDKN2A and glioblastoma: Oligo <sup>Cdkn2a</sup> tumors displayed metabolic and transcriptional changes associated with <i>IDH</i> and <i>CIC</i> mutations, and single cell sequencing identified a bias towards oligodendrocyte differentiation compared to an IDH wild-type glioblastoma mouse model.